{"\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Affection Status\\Disease status of participant\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\% of FVC predicted at diagnosis PFT\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\% of FVC predicted at most recent PFT\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\Annual FEV1 change between PFTs\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\Annual FVC change between PFTs\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\Change in FEV1/FVC ratio between diagnosis PFT and recent PFT (minimum 2 year interval)\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\FEV1/FVC ratio of PFT closest to diagnisis\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\FEV1/FVC ratio of most recent PFT\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Age at recording of phenotypes\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Bone and joint involvement\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Bone marrow involvement\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Cardiac involvement\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Certainty of diagnosis\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Chest x-ray at diagnosis recode\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Chest x-ray at diagnosis\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Chronic phenotype yes/no\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Extrathoracic lymph gland involvement\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Eye involvement\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Involvement of the liver, non-thoracic lymph glands or bone marrow\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Liver involvement\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Neuro involvement\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Non-thoracic_involvement\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Pulmonary phenotype severity score\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Radiographic resolution on repeat chest x-ray recode\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Radiographic resolution on repeat chest x-ray\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Renal involvement\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Resolution of sarcoid pulmonary involvement based on cxr (minimum 2 year fu)\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Skin involvement\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Spleen involvement\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Upper respiratory tract involvement including the sinuses\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Worst CXR during follow-up\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Sample Attributes\\TOPMed Phase\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Sociodemography and Administration\\Pedigree\\Sex\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Sociodemography and Administration\\Sociodemography\\Gender of participant\\": "All NaN", "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Sociodemography and Administration\\Subject IDs and Consents\\Consent group as determined by DAC\\": "All NaN"}